Most cited papers in Hemophilia Treatment and Research
What are the most cited papers in Hemophilia Treatment and Research?
The most cited paper in Hemophilia Treatment and Research is "Mutation in blood coagulation factor V associated with resistance to activated protein C" (Rogier M. Bertina, Bobby P. C. Koeleman, Ted Koster et al., 1994), with 3,854 citations. Next come "Hematological Problems in Pediatric Intensive Care" (3,516) and "WFH Guidelines for the Management of Hemophilia, 3rd edition" (2,029).
Showing 50 of 99 papers. Every paper with more than 534 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Mutation in blood coagulation factor V associated with resistance to activated protein C Rogier M. Bertina, Bobby P. C. Koeleman, Ted Koster et al. · Nature | May 1994 | 3,854 |
| 2 | Hematological Problems in Pediatric Intensive Care Shoshana Revel‐Vilk, Peter N. Cox, Nancy Robitaille et al. · Pediatric and adolescent medicine | 28 Nov 2013 | 3,516 |
| 3 | WFH Guidelines for the Management of Hemophilia, 3rd edition Alok Srivastava, Elena Santagostino, Alison Dougall et al. · Haemophilia | Aug 2020 | 2,029 |
| 4 | Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Björn Dahlbäck, Martin Carlsson, Peter J. Svensson · Proceedings of the National Academy of Sciences | Feb 1993 | 1,990 |
| 5 | Guidelines for the management of hemophilia Alok Srivastava, A. Brewer, Evelien P. Mauser‐Bunschoten et al. · Haemophilia | 6 Jul 2012 | 1,938 |
| 6 | EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update Josef S Smolen et al. · Annals of the Rheumatic Diseases | 10 Nov 2022 | 1,921 |
| 7 | Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B Amit C. Nathwani et al. · New England Journal of Medicine | 10 Dec 2011 | 1,875 |
| 8 | The coagulation cascade: initiation, maintenance, and regulation Earl W. Davie, Kazuo Fujikawa, Walter Kisiel · Biochemistry | Oct 1991 | 1,823 |
| 9 | Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection Eric Lawitz et al. · New England Journal of Medicine | 23 Apr 2013 | 1,794 |
| 10 | A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis Joan M. Bathon, Richard W. Martin, Roy Fleischmann et al. · New England Journal of Medicine | 30 Nov 2000 | 1,752 |
| 11 | The Ratio of Blood Products Transfused Affects Mortality in Patients Receiving Massive Transfusions at a Combat Support Hospital Matthew A. Borgman, Philip Charles Spinella, Jeremy G. Perkins et al. · The Journal of Trauma: Injury, Infection, and Critical Care | Oct 2007 | 1,590 |
| 12 | A Cell-based Model of Hemostasis Dougald M. Monroe, Maureane Hoffman · Thrombosis and Haemostasis | 2001 | 1,542 |
| 13 | Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty Bengt I. Eriksson, Lars C. Borris, Richard Joel Friedman et al. · New England Journal of Medicine | 25 Jun 2008 | 1,440 |
| 14 | BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR J. Evan Sadler · Annual Review of Biochemistry | Jun 1998 | 1,378 |
| 15 | Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection Nezam H. Afdhal et al. · New England Journal of Medicine | 12 Apr 2014 | 1,312 |
| 16 | Synthesis of Antihemophilic Factor Antigen by Cultured Human Endothelial Cells ERIC A. JAFFE, Leon W. Hoyer, Ralph L. Nachman · Journal of Clinical Investigation | Nov 1973 | 1,292 |
| 17 | Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B Amit Chunilal Nathwani et al. · New England Journal of Medicine | 20 Nov 2014 | 1,276 |
| 18 | Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage Stephan A. Mayer, Nikolai Constantin Brun, Kamilla Begtrup et al. · New England Journal of Medicine | 14 May 2008 | 1,265 |
| 19 | The molecular basis of blood coagulation Bruce Furie, Barbara C. Furie · Cell | May 1988 | 1,254 |
| 20 | Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Thomas A. Drake, James H. Morrissey, Thomas S. Edgington · PubMed | May 1989 | 1,199 |
| 21 | Development of the human coagulation system in the full-term infant M Andrew, Bosco A Paes, RUTH A. MILNER et al. · Blood | Jul 1987 | 1,190 |
| 22 | Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage Stephan A. Mayer, Nikolai Constantin Brun, Kamilla Begtrup et al. · New England Journal of Medicine | 23 Feb 2005 | 1,172 |
| 23 | World distribution of factor V Leiden David C. Rees, Michael J. Cox, J. B. Clegg · The Lancet | Oct 1995 | 1,170 |
| 24 | Resistance to Activated Protein C as a Basis for Venous Thrombosis Peter J. Svensson, Björn Dahlbäck · New England Journal of Medicine | 24 Feb 1994 | 1,130 |
| 25 | Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion C. A. Llewelyn, P. B Hewitt, RSG Knight et al. · The Lancet | Feb 2004 | 1,130 |
| 26 | Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic Purpura Joel L. Moake, Christine K. Rudy, Joseph H. Troll et al. · New England Journal of Medicine | 2 Dec 1982 | 1,119 |
| 27 | Emicizumab Prophylaxis in Hemophilia A with Inhibitors Johannes Oldenburg, Johnny Ndoni Mahlangu, Benjamin B. Kim et al. · New England Journal of Medicine | 10 Jul 2017 | 1,117 |
| 28 | The Hemophilias — From Royal Genes to Gene Therapy Pier Mannuccio Mannucci, Edward G. D. Tuddenham · New England Journal of Medicine | 7 Jun 2001 | 1,101 |
| 29 | Cochrane Injuries Group Albumin ReviewersWhy albumin may not work Abi Berger · BMJ | 25 Jul 1998 | 1,089 |
| 30 | Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men Paul M. Ridker, Charles H. Hennekens, Klaus Lindpaintner et al. · New England Journal of Medicine | 6 Apr 1995 | 1,057 |
| 31 | Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura Marie Scully, Spero R. Cataland, Flora Peyvandi et al. · New England Journal of Medicine | 9 Jan 2019 | 1,038 |
| 32 | Characterization of the human factor VIII gene Jane Gitschier, William I. Wood, Therese M. Goralka et al. · Nature | Nov 1984 | 1,001 |
| 33 | The Partial Thromboplastin Time with Kaolin: A Simple Screening Test for First Stage Plasma Clotting Factor Deficiencies Robert R. Proctor, Samuel I. Rapaport · American Journal of Clinical Pathology | Sep 1961 | 998 |
| 34 | Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and B I. M. Nilsson, Erik E. Berntorp, Thomas Löfqvist et al. · Journal of Internal Medicine | Jul 1992 | 971 |
| 35 | Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man Haig H. Kazazian, Corinne Kung Yen Wong, Hagop Youssoufian et al. · Nature | Mar 1988 | 946 |
| 36 | Molecular cloning of a cDNA encoding human antihaemophilic factor John J. Toole, John L. Knopf, John M. Wozney et al. · Nature | Nov 1984 | 942 |
| 37 | Maturation of the hemostatic system during childhood M Andrew, Patricia Vegh, Marilyn Johnston et al. · Blood | 15 Oct 1992 | 909 |
| 38 | Structure of human factor VIII Gordon A. Vehar, Bruce A. Keyt, Dan Eaton et al. · Nature | Nov 1984 | 899 |
| 39 | Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial David J. Kuter et al. · The Lancet | Feb 2008 | 872 |
| 40 | Surface-dependent reactions of the vitamin K-dependent enzyme complexes KG Mann, ME Nesheim, W R Church et al. · Blood | Jul 1990 | 861 |
| 41 | Acquired von Willebrand Syndrome in Aortic Stenosis André Vincentelli, Sophie Susen, Thierry Le Tourneau et al. · New England Journal of Medicine | 23 Jul 2003 | 852 |
| 42 | An Improved Method for Prenatal Diagnosis of Genetic Diseases by Analysis of Amplified DNA Sequences Scott C. Kogan, Marie Doherty, Jane Gitschier · New England Journal of Medicine | 15 Oct 1987 | 806 |
| 43 | Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A Delia Lakich, Haig H. Kazazian, Stylianos E. Antonarakis et al. · Nature Genetics | Nov 1993 | 802 |
| 44 | Recombinant Factor VIIa as Adjunctive Therapy for Bleeding Control in Severely Injured Trauma Patients: Two Parallel Randomized, Placebo-Controlled, Double-Blind Clinical Trials Kenneth David Boffard, Bruno Riou, Brian Warren et al. · The Journal of Trauma: Injury, Infection, and Critical Care | Jul 2005 | 786 |
| 45 | Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant Lindsey A. George et al. · New England Journal of Medicine | 6 Dec 2017 | 774 |
| 46 | High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism Paul Alexander Kyrle, Erich Minar, Mirko Hirschl et al. · New England Journal of Medicine | 17 Aug 2000 | 770 |
| 47 | Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors Johnny Ndoni Mahlangu, Johannes Oldenburg, Ido Paz‐Priel et al. · New England Journal of Medicine | 29 Aug 2018 | 769 |
| 48 | Haemophilias A and B Paula H. B. Bolton‐Maggs, John Pasi · The Lancet | May 2003 | 764 |
| 49 | Definitions in hemophilia: communication from the SSC of the ISTH Victor S. Blanchette, Nigel S. Key, L.R. Ljung et al. · Journal of Thrombosis and Haemostasis | 24 Jul 2014 | 763 |
| 50 | Hereditary Angioedema: New Findings Concerning Symptoms, Affected Organs, and Course Konrad Bork, Gabriele Meng, Petra Staubach et al. · The American Journal of Medicine | 21 Feb 2006 | 759 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.